Treatment of cutaneous actinomycosis with amoxicillin/clavulanic acid

References

• Valour F, Sénéchal A, Dupieux C, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. 2014;7:183–97.
   PubMed Web of Science ®Google Scholar
• Brook I. Actinomycosis: diagnosis and management. South Med J. 2008;101:1019–23.
   PubMed Web of Science ®Google Scholar
• Wong VK, Turmezei TD, Weston VC. Actinomycosis. BMJ. 2011;343:d6099. doi: 10.1136/bmj.d6099.
   PubMed Web of Science ®Google Scholar
• Rosales A, Bonifaz A. Actinomicosis. Revisión. Dermatol CMQ. 2005;3:200–10.
   Google Scholar
• Goldberg MH. Diagnosis and treatment of cervicofacial actinomycosis. Oral Maxillofac Surg Clin North Am. 2003;15:51–8.
   PubMedGoogle Scholar
• Garner JP, Macdonald M, Kumar PK. Abdominal actinomycosis. Int J Surg. 2007;5:441–8.
   PubMedGoogle Scholar
• Acevedo F, Baudrand R, Letelier LM, Gaete P. Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature. Int J Infect Dis. 2008;12:358–62.
   PubMed Web of Science ®Google Scholar
• Hermida MD, Della Giovanna P, Lapadula M, et al. Actinomyces meyeri cutaneous actinomycosis. Int J Dermatol. 2009;48:154–6.
   PubMed Web of Science ®Google Scholar
• Wagenlehner FM, Mohren B, Naber KG, Männl HF. Abdominal actinomycosis. Clin Microbiol Infect. 2003;9:881–5.
   PubMed Web of Science ®Google Scholar
• Hall V. Actinomyces-gathering evidence of human colonization and infection. Anaerobe. 2008;14:1–7.
   PubMed Web of Science ®Google Scholar
• Moghimi M, Salentijn E, Debets-Ossenkop Y, et al. Treatment of cervicofacial actinomycosis: a report of 19 cases and review of literature. Med Oral Patol Oral Cir Bucal. 2013;18:e627–32.
   PubMed Web of Science ®Google Scholar
• Oostman O, Smego RA. Cervicofacial actinomycosis: diagnosis and management. Curr Infect Dis Rep. 2005;7:170–4.
   PubMedGoogle Scholar
• Smith AJ, Hall V, Thakker B, Gemmell CG. Antimicrobial susceptibility testing of Actinomyces species with 12 antimicrobial agents. J Antimicrob Chemother. 2005;56:407–9.
   PubMed Web of Science ®Google Scholar
• Kolm I, Aceto L, Hombach M, et al. Cervicofacial actinomycosis: a long forgotten infectious complication of immunosuppression – report of a case and review of the literature. Dermatol Online J. 2014;20:22640.
   PubMedGoogle Scholar
• Lee EHL, Degener JE, Welling GW, Veloo ACM. Evaluation of the Vitek 2 ANC card for identification of clinical isolates of anaerobic bacteria. J Clin Microbiol. 2011;49:1745–9.
   PubMed Web of Science ®Google Scholar
• Pulverer G, Schütt-Gerowitt H, Schaal KP. Human cervicofacial actinomycoses: microbiological data for 1997 cases. Clin Infect Dis. 2003;37:490–7.
   PubMed Web of Science ®Google Scholar
• Donohue DE, Brightman AH 2nd. Cervicofacial Actinomyces viscosus infection in a Brazilian fila: a case report and literature review. J Am Anim Hosp Assoc. 1995;31:501–5.
   PubMed Web of Science ®Google Scholar
• Vorasubin N, Wu AW, Day C, Suh JD. Invasive sinonasal actinomycosis: case report and literature review. Laryngoscope. 2013;123:334–8.
   PubMed Web of Science ®Google Scholar
• Lancella A, Abbate G, Foscolo AM, Dosdegani R. Two unusual presentations of cervicofacial actinomycosis and review of the literature. Acta Otorhinolaryngol Ital. 2008;28:89–93.
   PubMed Web of Science ®Google Scholar
• Mueller MC, Ihrler S, Degenhart C, Bogner JR. Abdominal actinomycosis. Infection. 2008;36:191.
   PubMed Web of Science ®Google Scholar
• Chelli D, Hassini A, Aloui F, et al. Actinomycose pelvienne Expérience tunisienne: à propos de 5 cas. Sante. 2008;18:77–82.
   PubMedGoogle Scholar
• Könönen E, Wade WG. Actinomyces and related organisms in human infections. Clin Microbiol Rev. 2015;28:419–42.
   PubMed Web of Science ®Google Scholar
• Casarin RC, Barbagallo A, Meulman T, et al. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J Periodont Res. 2013;48:30–6.
   PubMed Web of Science ®Google Scholar
• de Andrade AL, Novaes MM, Germano AR, et al. Acute primary actinomycosis involving the hard palate of a diabetic patient. J Oral Maxillofac Surg. 2014;72:537–41.
   PubMed Web of Science ®Google Scholar
• Zhou M, Rong R, Munro D, et al. Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing. PLoS One. 2013;8:e61516. doi: 10.1371/journal.pone.0061516.
   PubMed Web of Science ®Google Scholar
• Kuyama K, Fukui K, Ochiai E, et al. Identification of the actinomycete 16S ribosomal RNA gene by polymerase chain reaction in oral inflammatory lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;116:485–91.
   PubMed Web of Science ®Google Scholar
• Stein GE, Gurwith MJ. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination. Clin Pharm. 1984;3:591–9.
   PubMedGoogle Scholar
• Gillies M, Ranakusuma A, Hoffmann T, et al. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. Cmaj 2015;187:E21–31.
   PubMed Web of Science ®Google Scholar
• Pinheiro ET, Gomes BP, Ferraz CC, et al. Evaluation of root canal microorganisms isolated from teeth with endodontic failure and their antimicrobial susceptibility. Oral Microbiol Immunol. 2003;18:100–3.
   PubMedGoogle Scholar
• Gomes BP, Jacinto RC, Montagner F, et al. Analysis of the antimicrobial susceptibility of anaerobic bacteria isolated from endodontic infections in Brazil during a period of nine years. J Endod. 2011;37:1058–62.
   PubMed Web of Science ®Google Scholar
• van Winkelhoff AJ, Winkel EG, Barendregt D, et al. beta-Lactamase producing bacteria in adult periodontitis. J Clin Periodontol. 1997;24:538–43.
   PubMed Web of Science ®Google Scholar
• Sudhakar SS, Ross JJ. Short-term treatment of actinomycosis: two cases and a review. Clin Infect Dis. 2004;38:444–7.
   PubMed Web of Science ®Google Scholar
• Richardson WL, Hammert WC. Adverse effects of common oral antibiotics. J Hand Surg Am. 2014;39:989–91.
   PubMed Web of Science ®Google Scholar
• Choi J, Koh WJ, Kim TS, et al. Optimal duration of IV and oral antibiotics in the treatment of thoracic actinomycosis. Chest. 2005;128:2211–7.
   PubMed Web of Science ®Google Scholar
• Steininger C, Willinger B. Resistance patterns in clinical isolates of pathogenic Actinomyces species. J Antimicrob Chemother. 2016;71:422–7.
   PubMed Web of Science ®Google Scholar